Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.

Pierce, G F; Tarpley, J E; Allman, R M; Goode, P S; Serdar, C M; Morris, B; Mustoe, T A; Vande Berg, J

Pierce, G F; Tarpley, J E; Allman, R M; Goode, P S; Serdar, C M; Morris, B; Mustoe, T A; Vande Berg, J.

Affiliation

Pierce GF; Department of Experimental Pathology, Amgen Inc., Thousand Oaks, California.

Am J Pathol ; 145(6): 1399-410, 1994 Dec.

Article in En | MEDLINE | ID: mdl-7992843

Subject(s)

Platelet-Derived Growth Factor/therapeutic use; Pressure Ulcer/drug therapy; Pressure Ulcer/physiopathology; Wound Healing/drug effects; Antibodies/immunology; Becaplermin; Biopsy; Blood Vessels/growth & development; Chronic Disease; Cohort Studies; Collagen/metabolism; Double-Blind Method; Fibroblasts/pathology; Humans; Peptide Fragments/immunology; Placebos; Pressure Ulcer/pathology; Procollagen/chemistry; Proto-Oncogene Proteins c-sis; Recombinant Proteins

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Wound Healing / Platelet-Derived Growth Factor / Pressure Ulcer Type of study: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies Limits: Humans Language: En Journal: Am J Pathol Year: 1994 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google